The antibody binds to the programmed cell death protein-1 (PD-1) receptor on cytotoxic T cells, blocking their interaction with programmed cell death protein-L1 (PD-L1) on tumor cells, thereby triggering T-cell-mediated anti-tumor responses [8]. This evidence concerns the gene PDCD1 and neoplasm.